Phase II Trial of Etoposide in Leiomyosarcoma of the Uterus: A Gynecologic Oncology Group Study

By Thigpen T.   Blessing J.A.   Yordan E.   Valea F.   Vaccarello L.  

Gynecologic Oncology, Vol. 63, Iss. 1, 1996-10 ,pp. : 120-122

Academic Press

Access to resources Recommend Favorite

A Phase II Trial of Prolonged Oral Etoposide (VP-16) as Second-Line Therapy for Advanced and Recurrent Endometrial Carcinoma: A Gynecologic Oncology Group Study

By Rose P.G.   Blessing J.A.   Lewandowski G.S.   Creasman W.T.   Webster K.D.  

Gynecologic Oncology, Vol. 63, Iss. 1, 1996-10 ,pp. : 101-104

Academic Press

Access to resources Recommend Favorite

A Phase I Trial of Prolonged Oral Etoposide and Liposomal Doxorubicin in Ovarian, Peritoneal, and Tubal Carcinoma: A Gynecologic Oncology Group Study

By Rose P.G.   Rodriguez M.   Walker J.   Greer B.   Fusco N.   McGuire W.  

Gynecologic Oncology, Vol. 85, Iss. 1, 2002-04 ,pp. : 136-139

Elsevier

Access to resources Recommend Favorite

Bleomycin, Etoposide, and Cisplatin Combination Therapy of Ovarian Granulosa Cell Tumors and Other Stromal Malignancies: A Gynecologic Oncology Group Study

By Homesley H.D.   Bundy B.N.   Hurteau J.A.   Roth L.M.  

Gynecologic Oncology, Vol. 72, Iss. 2, 1999-02 ,pp. : 131-137

Elsevier

Access to resources Recommend Favorite

Phase II Trial of Hydroxyurea, Dacarbazine (DTIC), and Etoposide (VP-16) in Mixed Mesodermal Tumors of the Uterus: A Gynecologic Oncology Group Study

By Currie J.L.   Blessing J.A.   McGehee R.   Soper J.T.   Berman M.  

Gynecologic Oncology, Vol. 61, Iss. 1, 1996-04 ,pp. : 94-96

Academic Press

Access to resources Recommend Favorite